Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Life and Health Insurance Industry Analysis

UpdatedAug 26, 2026
DataAggregated Company Financials
Companies21
  • 7D-2.6%
  • 3M9.2%
  • 1Y14.8%
  • YTDn/a

Over the last 7 days, the Life and Health Insurance industry has dropped 1.8%, driven by a pullback from Aflac of 4.6%. This takes the industry's 12 month performance to a gain of 16%. Looking forward, earnings are forecast to grow by 7.9% annually.

Industry Valuation and Performance

Has the U.S. Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 26 Aug 2026US$271.9bUS$273.7bUS$21.1b15.8x12.9x1x
Fri, 24 Jul 2026US$273.7bUS$264.9bUS$18.7b13.7x14.6x1x
Sun, 21 Jun 2026US$257.7bUS$264.8bUS$18.7b15.2x13.8x1x
Tue, 19 May 2026US$251.2bUS$264.8bUS$18.7b13.7x13.4x0.9x
Thu, 16 Apr 2026US$241.2bUS$260.4bUS$16.6b15.5x14.5x0.9x
Sat, 14 Mar 2026US$224.7bUS$260.6bUS$16.7b13.9x13.5x0.9x
Mon, 09 Feb 2026US$241.9bUS$258.4bUS$19.4b12.9x12.4x0.9x
Wed, 07 Jan 2026US$256.2bUS$255.6bUS$19.7b13.2x13x1x
Fri, 05 Dec 2025US$244.8bUS$255.6bUS$19.7b12.3x12.4x1x
Sun, 02 Nov 2025US$244.2bUS$254.0bUS$18.1b12.7x13.5x1x
Tue, 30 Sep 2025US$255.6bUS$254.5bUS$15.7b13.3x16.3x1x
Thu, 28 Aug 2025US$251.5bUS$254.5bUS$15.7b13.9x16.1x1x
Sat, 26 Jul 2025US$244.0bUS$257.6bUS$18.1b12.3x13.4x0.9x
Mon, 23 Jun 2025US$227.0bUS$243.3bUS$17.6b12.3x12.9x0.9x
Wed, 21 May 2025US$233.1bUS$243.3bUS$17.6b12.6x13.2x1x
Fri, 18 Apr 2025US$219.1bUS$250.3bUS$22.4b10.3x9.8x0.9x
Sun, 16 Mar 2025US$236.1bUS$250.3bUS$22.4b11x10.5x0.9x
Tue, 11 Feb 2025US$235.0bUS$244.6bUS$20.0b12.1x11.7x1x
Thu, 09 Jan 2025US$231.2bUS$242.9bUS$14.3b13.7x16.2x1x
Sat, 07 Dec 2024US$243.7bUS$242.9bUS$14.3b14.5x17.1x1x
Mon, 04 Nov 2024US$230.3bUS$240.3bUS$14.5b15.3x15.8x1x
Wed, 02 Oct 2024US$239.5bUS$229.8bUS$16.6b13.4x14.4x1x
Fri, 30 Aug 2024US$234.4bUS$229.8bUS$16.6b13x14.1x1x
Sun, 28 Jul 2024US$228.1bUS$223.6bUS$14.7b10.1x15.5x1x
Tue, 25 Jun 2024US$219.2bUS$225.4bUS$14.8b10.6x14.8x1x
Thu, 23 May 2024US$216.5bUS$225.4bUS$14.8b10.4x14.6x1x
Sat, 20 Apr 2024US$206.3bUS$216.9bUS$10.3b15.9x20.1x1x
Mon, 18 Mar 2024US$218.9bUS$216.9bUS$10.3b15x21.3x1x
Wed, 14 Feb 2024US$210.2bUS$209.2bUS$10.0b12.2x21x1x
Fri, 12 Jan 2024US$257.9bUS$213.6bUS$2.7b13.3x95.3x1.2x
Sun, 10 Dec 2023US$250.8bUS$216.4bUS$1.6b13.2x154x1.2x
Tue, 07 Nov 2023US$242.9bUS$216.0bUS$1.7b11x141.1x1.1x
Thu, 05 Oct 2023US$240.5bUS$238.9bUS$1.0b12.4x235.3x1x
Sat, 02 Sep 2023US$244.8bUS$238.9bUS$1.0b13.3x239.4x1x
Price to Earnings Ratio

239.4x


Total Market Cap: US$244.8bTotal Earnings: US$1.0bTotal Revenue: US$238.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life and Health Insurance Industry Price to Earnings3Y Average 37.2x202420252026
Current Industry PE
  • Investors are pessimistic on the American Life and Health Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.7x which is lower than its 3-year average PE of 37.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.99x.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have grown 174% per year over the last three years.
  • Revenues for these companies have grown 4.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Life and Health Insurance compare with similar industries?

US Market-0.31%
Financials0.89%
Insurance1.17%
Life and Health Insurance-2.56%
Insurance Brokers4.80%
Reinsurance1.50%
Property and Casualty Insurance1.00%
General Insurance-1.23%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BNT Brookfield Wealth SolutionsUS$42.230.1%
+US$21.5m		-3.0%PE120.8x
CIA CitizensUS$3.892.4%
+US$4.6m		-27.6%PE17x

Latest News

GL
US$172.24
Globe Life
7D
-3.3%
1Y
23.3%
Seeking Alpha • 1h

Globe Life Q2: Solid Fundamentals, But GL.PR.D Offers A Better Risk-Adjusted Yield Near 7.8%

Summary Globe Life Inc. demonstrates robust financial health, with strong net income growth and investment-grade credit ratings. GL's baby bond offers a 7.8% yield to worst, trades below par, and has nearly 6.4% capital appreciation potential. I maintain a 'hold' on GL common stock due to valuation but rate the baby bond a 'buy' for its risk-reward profile. GL boasts 36 consecutive years of dividends and a new $2.5 billion share repurchase authorization, supporting shareholder returns. Read the full article on Seeking Alpha
LNC
US$42.61
Lincoln National
7D
-5.5%
1Y
0%
MET
US$95.87
MetLife
7D
-0.9%
1Y
18.3%
Narrative Update • Aug 22

MET: Buybacks And New Liquidity Features Will Shape A Balanced Forward Risk Profile

Analysts have raised their price target for MetLife to $104.38 from $100.44, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a higher valuation framework. What’s in the News for MetLife MetLife announced a share repurchase program authorizing up to US$3.0b of common stock buybacks.
PRI
US$297.72
Primerica
7D
-3.4%
1Y
11.1%
Narrative Update • Aug 21

PRI: Buybacks And Stable Cash Flows Will Support Measured Future Returns

Analysts have raised their Primerica price target to $328.67 from $317.83, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as support for the revision. What’s in the News for Primerica Primerica reported Q2 2026 revenue of about US$865.1 million, which the company said was in line with Wall Street expectations.
FG
US$23.04
F&G Annuities & Life
7D
-9.8%
1Y
-33.6%
PRU
US$120.15
Prudential Financial
7D
-3.5%
1Y
9.8%
Narrative Update • Aug 20

PRU: Higher Earnings Hopes Will Sustain Overvaluation Risk Despite Japan Conduct Issues

Analysts have increased their fair value estimate for Prudential Financial to about $111 from roughly $107, reflecting a series of higher Street price targets that cite stronger sector valuations, slightly improved long-term earnings expectations, and company-specific cost savings. Analyst Commentary Recent research on Prudential Financial shows a cluster of higher price targets, but also a split in how comfortable analysts feel about execution and risk.
PFG
US$111.59
Principal Financial Group
7D
-1.4%
1Y
38.5%
Narrative Update • Aug 19

PFG: Future Capital Returns And Earnings Resilience Will Support Balanced Upside Potential

Analysts nudged the fair value estimate for Principal Financial Group higher to about $109.58 from roughly $107.33, citing updated revenue and valuation assumptions in recent price target revisions across the Street. Analyst Commentary Recent Street research on Principal Financial Group shows a mix of optimism and caution, with several firms lifting price targets while keeping a wide spread of ratings from Underperform to Overweight.
BNT
US$42.23
Brookfield Wealth Solutions
7D
0.1%
1Y
-3.0%
CIA
US$3.89
Citizens
7D
2.4%
1Y
-27.6%
AFL
US$116.18
Aflac
7D
-4.6%
1Y
7.4%